GLP-1 & Weight Management

Research peptides for metabolic and weight management studies including GLP-1 receptor agonists, dual and triple agonists, and metabolic modulators.
View as Grid List
Sort by
Display per page

Tesofensine

Tesofensine (NS2330) triple monoamine reuptake inhibitor. Inhibits SERT/NET/DAT transporters (IC₅₀ 1.7-65 nM). C₁₇H₂₃Cl₂NO, 328.28 Da, CAS 195875-84-4. ~9-day half-life. ≥98% purity. Lab research only.

$170.00 $124.00

Tirzepatide

  • Dual Incretin Agonist: 39-residue twincretin engaging GIPR and GLP-1R, ≥98% HPLC purity
  • Biased GLP-1R Signaling: Favors Gs/cAMP over β-arrestin recruitment in receptor pharmacology research
  • Energy-Balance Studies: Investigational compound for metabolic-pathway and incretin biology research
$99.00

Retatrutide (5mg)

  • Triple-Receptor Agonist: 39-amino acid synthetic peptide, 4,731.33 Da, ≥95% purity by HPLC
  • GIPR / GLP-1R / GCGR Signaling: EC₅₀ 0.064 / 0.775 / 5.79 nM at human receptors (cAMP)
  • Energy-Homeostasis Research: 5 mg lyophilized peptide for in vitro and animal-model investigation
$69.00

Cagrilintide (10mg)

Cagrilintide - Long-acting amylin analog activating AMY1R/AMY2R/AMY3R and CALCR receptors. ≥98% purity (HPLC). Half-life 159-195 hours. For laboratory research only.

$99.00

Cagri-Sema Blend (5 mg, 5 mg)

Cagrilintide 5mg / Semaglutide 5mg research blend for laboratory studies. Pharmaceutical-grade dual peptide for in-vitro research only. Not for human consumption.

$129.00

Tirz, Cagrilintide (10 mg, 5 mg)

Cagrilintide 5mg / Tirzepatide 10mg research blend for laboratory studies. Pharmaceutical-grade peptides for in-vitro research only. Not for human consumption.

$199.00